CA2402609A1 — Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives

USPTO Abstract

Glucopyranosyloxybenzylbenzene derivatives of the general formula (I) and salts thereof, which exhibit excellent human SGLT2 inhibiting activity and are useful as preventive or therapeutic drugs for diabetes, obesity and so on; and intermediates for the preparation of the derivatives wherein R1 is hydrogen or hydroxylated lower alkyl; R2 is lower alkyl, lower alkoxy, lower alkylthio, hydroxylated lower alkyl, hydroxylated lower alkoxy, hydroxylated lower alkylthio, or the like.